Novavax Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,818	1,092	1,288	570	884	10,817
Market Cap Growth	38.61%	-15.21%	125.87%	-35.49%	-91.83%	165.21%
Enterprise Value	1,332	580	641	178	300	9,339
Last Close Price	11.19	6.72	8.04	4.80	10.28	143.07
PE Ratio	4.34	2.48	-	-	-	-
Forward PE	-	-	-	-	-	10.46
PS Ratio	1.62	0.97	1.89	0.58	0.45	9.44
PB Ratio	-	-8.55	-2.06	-0.79	-1.39	-30.76
P/FCF Ratio	-	-	-	-	-	40.30
P/OCF Ratio	-	-	-	-	-	33.50
EV/Sales Ratio	1.19	0.52	0.94	0.18	0.15	8.15
EV/EBITDA Ratio	2.30	1.00	-	-	-	-
EV/EBIT Ratio	2.42	1.05	-	-	-	-
EV/FCF Ratio	-	-	-	-	-	34.79
Debt / Equity Ratio	-1.95	-1.95	-0.42	-0.39	-0.97	-1.49
Debt / EBITDA Ratio	0.43	0.43	-	-	-	-
Debt / FCF Ratio	-	-	-	-	-	1.95
Net Debt / Equity Ratio	3.81	3.81	1.06	0.40	1.14	2.82
Net Debt / EBITDA Ratio	-0.84	-0.84	3.60	0.56	1.17	0.59
Net Debt / FCF Ratio	1.94	1.94	6.58	0.38	1.43	-3.69
Asset Turnover	0.82	0.82	0.41	0.49	0.82	0.55
Inventory Turnover	7.20	7.20	22.59	26.47	90.94	-
Quick Ratio	1.83	1.83	0.89	0.53	0.58	0.82
Current Ratio	2.13	2.13	0.98	0.70	0.69	0.90
Return on Equity (ROE)	-	-	-	-	-	-1265.71%
Return on Assets (ROA)	25.15%	25.15%	-8.63%	-17.02%	-16.67%	-50.69%
Return on Capital Employed (ROCE)	76.80%	76.80%	-57.10%	-340.10%	320.30%	-904.70%
Earnings Yield	24.21%	40.32%	-14.56%	-95.59%	-74.44%	-16.12%
FCF Yield	-13.76%	-22.91%	-7.79%	-134.64%	-57.14%	2.48%
Buyback Yield / Dilution	-13.74%	-13.74%	-51.03%	-28.89%	-5.08%	-29.27%

Updated Feb 26, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q